FIELD: pharmacy.
SUBSTANCE: present invention relates to a pharmaceutical composition for the treatment and/or prevention of cancer, which contains, as an active ingredient, an antibody or a fragment thereof having immunological reactivity with the MRAP2 protein having the amino acid sequence shown in SEQ ID No. 2, 4, 6 or 8, or an amino acid sequence having 80% or more sequence identity with the amino acid sequence or with a fragment of the MRAP2 protein containing 7 or more consecutive amino acids.
EFFECT: malignant tumour treatment and/or malignant tumour prevention.
8 cl, 4 ex, 4 dwg
